Table 5.

Psychiatric conditions and treatment

PSYCHIATRIC CONDITION OR TREATMENT	SITE, N (%)			TOTAL COHORT (N = 102), N (%)	P VALUE
PSYCHIATRIC CONDITION OR TREATMENT	TORONTO (N = 44)	VANCOUVER (N = 36)	MONTREAL (N = 22)	TOTAL COHORT (N = 102), N (%)	P VALUE
Psychiatric condition
• Major depression	16 (36)	21 (58)	9 (41)	46 (45)	.131
• Anxiety disorder	14 (32)	5 (14)	2 (9)	21 (21)	.058
• Other^*	5 (11)	8 (22)	4 (18)	17 (17)	.429
• Abuse (physical or sexual)	21 (48)	12 (33)	3 (14)	36 (35)	.023^†
• Suicidal thoughts or attempts	9 (20)	5 (14)	1 (5)	15 (15)	.224
Current pharmacotherapy
• Benzodiazepines	6 (14)	24 (67)	5 (23)	35 (34)	< .001^†
• Antipsychotics	0 (0)	4 (11)	0 (0)	4 (4)	NA
• Other^‡	16 (36)	10 (28)	9 (41)	35 (34)	.552

NA—not applicable.
↵* Includes schizophrenia, bipolar disorder, and eating disorders.
↵† Indicates significant difference at P < .05.
↵‡ Consists of selective serotonin reuptake inhibitors, selective noradrenergic reuptake inhibitors, trazodone, and bupropion.